Conventional speaking your post is correct about a certain steering towards commercialisation focus.
A year to date, we were hoping for success in intravenous application...
It appears, according to Ann, that part of this is achieved.
Without personal bias, maybe the answers lie here to the current uncertainties..
So, it appears that a year on, the science has and continues to go forward and commercially awareness has began.
IMO only.
Ann: Director Resignation, page-9
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $909.8M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 18.5¢ | $331.8K | 1.731M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 711601 | 7 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |